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Abstract
Background: A Drum Dock Manager in an auto manufacturing company suffers a pelvic fracture, severing the bulbar
urethra and completely fracturing the right side of his pelvis.
He is unable to void without catheterization but has a complete sensation to void. Can neuromodulation help him
achieve spontaneous voiding?
Case presentation: We reviewed the electronic medical record of Mr. M.E. from Detroit Medical Center following his
2012 forklift accident and subsequent orthopedic surgeries. He successfully underwent bilateral sacral neuromodulation,
with a resulting max flow of 16.8 mls/sec and post-void residual urine of 50–100 mls. Unfortunately, he later presented
with bilateral pocket and sacral lead infection, and both systems had to be removed. Six weeks later, M.E. had bilateral
pudendal neurostimulation placement to avoid the previously infected areas. Max flow improved to 14.5 mls/sec and
0–50 mls residual urine. However, urodynamics proved that his Pdet at max flow was in excess of 120 cm of H20
pressure while he had been on finesteride and tamsulosin for the preceding five years for the management of his
documented benign prostate hyperplasia symptoms. He underwent Green light laser transurethral resection of the
prostate and had max flow improvement to 22.5 mls/second with zero residual urine with multiple straight
catheterization confirmations.
Conclusion: Sacral neuromodulation may successfully correct traumatic urinary retention in male patients. Additionally,
pudendal neuromodulation can be successfully utilized as a salvage method for an infected sacral neuromodulation
impulse generator (IPG) and tined lead with a return to proper voiding.
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Background
Traumatic urethral injury may result in partial or total
urinary retention in male patients. Clean intermittent
catheterization or chronic indwelling Foley catheterization
are frequently instituted to properly empty the bladder as
a temporary or permanent treatment measure. However,
after primary healing of 6 months or more, consideration
may be given to the surgical treatment of urinary retention
[1]. In the literature, sacral neuromodulation has report-
edly been utilized following surgical trauma but not blunt
or penetrating trauma. We now report the first case in the
literature utilizing bilateral sacral neuromodulation
followed by bilateral pudendal neuromodulation after an
industrial accident left our male patient with a severe
pubic symphysis fracture and subsequent urinary
retention.
Case presentation
M.E. is a 50-year-old Caucasian male, working as a Drum
Dock Manager in a car manufacturing factory. On April 23,
2012, as he was unloading a forklift, the machine automat-
ically engaged itself, speeding toward him and running him
over. His quick-thinking co-workers positioned him flat on
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the floor with his head tilted to the left. M.E. was conscious
and complaining of severe chest and pelvic pain. When
emergency medical services arrived, he was stable. A deci-
sion was made to fly him to a nearby Trauma One Medical
Center. He was diagnosed with seven left-sided rib frac-
tures, transection of the pubic symphysis (Fig. 1), and L1-L3
transverse process fractures. There was blood at his ureth-
ral meatus, and after a retrograde urethrogram (RUG) with
live fluoroscopy and without a hard copy print, a guide wire
was placed through a cystoscope and into the bladder with
fluoroscopic confirmation. M.E. later underwent orthopedic
stabilization and repair of his pubis symphysis. His lumbar/
sacral MRI redemonstrated the lumbar transverse fractures
with moderate degenerative lumbar disc disease without
nerve impingement (Fig. 2). The RUG demonstrated bulbar
extravasation, but a Council tip catheter was successfully
guided into the bladder to determine urethral continuity.
At 6 weeks, his RUG demonstrated a well-healed urethra.
He was given multiple trials of voids after being able to am-
bulate well for one month, but in spite of a sensation to
void, he could not generate a detrusor pressure, and no
voiding occurred. He failed two more trials of void. A uro-
dynamics study was then performed (Fig. 3), demonstrating
a first desire to void at 155 mls. Even at 550 mls, he experi-
enced a strong desire to void but no detrusor pressure. The
patient had good rectal sphincter tone and could volition-
ally tighten his rectum, so the pudendal nerve was assumed
to be working well. We recommended a minimally invasive
approach of sacral neuromodulation, which he successfully
underwent 6 months after the accident. His bellows and ip-
silateral plantar flexion were arrived at two volts on lead 0,
1 and 2, and at three volts on lead 3. Within six hours of
surgery, he was emptying half his bladder, and post void
residuals were 300 mls with straight catheterization.
After 2 months of follow-up, he continued to urinate at
maximum flows of 17.2 mls/sec but with 250–300
residual urines, so another sacral neuromodulation was
performed on his contralateral side. He immediately
improved to straight catheterization residual urine of
50–100 mls with a max flow of 16.8 mls/sec with 400
mls voided. Unfortunately 6 months later, after M.E.
had returned to work, his uniform was irritating both of
his implants, and within 3 weeks, he had a bilateral
cellulitis with purulent drainage from both lead sites
and implantable pulse generators. At surgery to
remove each implants each buttock pocket wound
culture grew non-methicillin resistant Staph aureus
and he was subsequently treated with Ciprofloxin
home intravenous therapy for six weeks and the
resumption of clean intermittent catheterization. Three
months later, re-examination revealed both sites to be
well healed. Our next alternative was bilateral pudendal
neuromodulation (Table 1), which would avoid placement
near or cross over with the two formerly infected sites.
Bilateral pudendal neuromodulation was performed
with a right and left 0–3 lead result of 1,1,2,4, and
2,2,4,5 volts, and within six hours, the patient began to
void without difficulty with a straight catheterization
post-void residual urine of 0–50 mls and a max flow of
14.5 mls/sec. We then performed urodynamics, which
demonstrated high pressure voiding with Pdet greater
than 120 cm H2O. While having been on both tamsulosin
Fig. 1 This plain film illustrates a right ischial pelvic fracture
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and finesteride for more than 5 years, M.E. had failed
medical therapy and was a high pressure voider. Sustained
high pressure is well known to damage the bladder
much like hypertension can damage the heart. To pro-
tect his bladder, we recommended a Green light
transurethral resection of the prostate, which was
performed on July 17, 2014. His subsequent straight
catheterization post void residual urines had been 0–50 mls
and his mean max flow was 22.6 mls/sec. With one-year of
follow-up, his voiding parameters remain stable while his
treatment power on both implantable pulse generators has
been 2.8 volts on the right and 4.2 volts on the left. He feels
perineal sensation and is without discomfort. We now
follow the patient in 4-month intervals.
Discussion
Treatment of complete detrusor areflexia has included
Valsalva voiding, intermittent straight catheterization,
chronic Foley catheterization, and most recently sacral
neuromodulation. Women achieve higher success rates
than men with sacral neuromodulation, but the use of
pudendal neuromodulation [2–8], particularly dual
pudendal neuromodulation for the treatment of detrusor
areflexia, has not been described. Several physicians with
whom I have communicated have stated that pudendal
neuromodulation for male urinary retention does not
work well. How sacral and pudendal neuromodulation
work to treat both overactive bladder symptoms and, to
a lesser extent, urinary retention has not been clearly
Fig. 2 This lateral lumbar Magnetic Resonance Image demonstrates severe degenerative disc disease with a few bulging intervertebral discs
Fig. 3 The written report of this patient’s first multichannel urodynamics study
Marinkovic et al. BMC Urology  (2015) 15:115 Page 3 of 4
defined. What is important to note is that the lower the
voltage level achieved to elicit good motor provocation
during sacral neuromodulation (bellows and ipsilateral big
toe plantar flexion and potentially pudendal neuromodu-
lation anal wink with an EMG documented EMG tracing
at less than or equal to 3 volts at one or more leads) the
better the end result for urinary retention and overactive
bladder symptoms. Our patient had both bilateral sacral
neuromodulation and bilateral pudendal neuromodulation
and feels that pudendal neuromodulation has given him
the closest sensation and performance to his normal void-
ing prior to the 2012 accident. He has also noticed an im-
provement in erections. While he was unable to have any
erections without a phosphodiesterase 5 inhibitor for two
years prior to the accident, he now can manage an erec-
tion without any medication. His voiding max flow and
post-void residuals are now normal for his age, and he
checks his post void residual via a home ultrasound device
provided free of charge for his use. Pudendal neuromodu-
lation is used as a salvage surgical operation for those
who, with sacral neuromodulation, experience a decrease
in efficacy and now fail to meet treatment expectations.
Pudendal neuromodulation has not been described for
urinary retention, but with our patient, the procedure
appears to have improved his outcome after volitional
voiding was not previously possible and his sacral
implants became infected. We hope that with this patient’s
continued success, we can appreciate the potential
utilization of pudendal neuromodulation when sacral neu-
romodulation has failed for urinary retention.
Conclusion
Sacral neuromodulation may successfully correct trau-
matic urinary retention, in male patients. Additionally,
pudendal neuromodulation can be successfully utilized
as a salvage method for an infected sacral neuromodula-
tion impulse generator (IPG), and tined lead with a
return to proper voiding.
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Table 1 Multichannel urodynamics report
1st Sensation 165 mls
1st Desire to Void 389 mls
Strong Desire to Void 510 mls
Pabd 51 cm H2O
Pdet 0 cm H2O
Max Flow 0 ml/sec
Cough Leak Point Pressure No leak
Rectal Tone Contracts external sphincter around a finger
in his rectum, indicating that the pudendal
nerve is working well
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